The role of locoregional radiotherapy in distant metastatic nasopharyngeal carcinoma cases
Background: Nasopharyngeal carcinoma (NPC) is a highly metastatic head and neck cancer primarily
treated with platinum-based chemotherapy. The oligometastasis hypothesis proposed by Hellman and
Weichselbaum suggested that controlling the primary tumor through locoregional radiotherapy could
significantly improve prolonged disease-free survival. Purpose: To evaluate the effectiveness of combining locoregional radiotherapy with chemotherapy for metastatic NPC. Case series report: The first case involved a 57-year-old male with NPC at T4N3M1 (lungs) with partial response to chemotherapy, who then underwent concurrent chemoradiotherapy. However, his condition deteriorated after completing chemoradiation. The second case featured a 56-year-old male with NPC at T4N3M1 (liver), exhibiting partial response to chemotherapy and remaining at a stable condition after concurrent chemoradiotherapy. Method: Using specific keywords based on clinical questions in the PubMed, Cochrane, EBSCOhost, and Proquest databases. Inclusion criteria, exclusion criteria, and critical appraisal were carried out to find relevant studies. Result: Eleven articles were appraised critically based on the Oxford Centre for Evidence-based Medicine (CEBM) worksheet and include the validity, importance, and applicability in clinical scenarios. Conclusion: Metastatic NPC patients had better overall survival outcomes when treated with locoregional radiotherapy and systemic chemotherapy. Predictive factors influencing survival included oligometastasis, locoregional radiotherapy, chemotherapy response, lactate dehydrogenase, C-reactive protein, EBV DNA, total chemotherapy administration, Karnofsky performance score, number of metastatic lesions, and liver metastases. Platinum-based chemotherapy combined with locoregional radiotherapy could be considered as a management approach for cases of oligometastatic NPC.
Keywords: nasopharyngeal carcinoma, chemotherapy, metastasis, overall survival, radiotherapy
Copyright (c) 2023 Ika Dewi Mayangsari, Muhammad Ade Rahman, Marlinda Adham, Gregorius Ben Prajogi, Rahmat Cahyanur, Eka Dian Safitri
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.